What would be the Future for Valves in the Pharmaceutical Industry?

Valves are pipe accessories used to open and close the pipeline, control the flow direction, adjust and control the parameters (temperature, pressure, and flow) of the conveying medium. From the perspective of the industrial chain, the upstream of the valve industry corresponds to the production of industrial raw materials such as castings, forgings, and seals. Among them, castings are the key components of valve production. The supply efficiency and quality directly determine the delivery of valve manufacturers and quality of valve products. As a key component of fluid control, the valve is widely used, and it is an essential element in the chemical, food, pharmaceutical and other industries. Among them, users in the pharmaceutical industry are highly concerned about the valve market. Since drugs are special commodities, their production requirements are very strict, and the requirements for valves are also increasing.

According to the "Forecast and Investment Strategic Planning Analysis Report of China's Pharmaceutical Industry 2018-2023" released by the Institute of Foresight Industry, the total sales revenue and profit of China's pharmaceutical manufacturing industry in 2017 were 292.6 billion yuan and 351.97 billion yuan, respectively, which was higher than the previous year. With the improvement of people's health awareness, the expansion of demand for medicines, the continuous promulgation of related pharmaceutical policies, and the continuous improvement of China's pharmaceutical production capacity, the income and profit levels of China's pharmaceutical industry will continue to grow. As an integral part of the pharmaceutical industry, pharmaceutical valves will also usher in good development opportunities.

At present, there are various types of valve products in the market, and different valves have different structures and applicable scopes. Among them, valves mainly applicable to the pharmaceutical industry are diaphragm valves, disc ball valves, non-retention ball valves and so on.

In the clean pipeline system of the pharmaceutical industry, due to its special design, the diaphragm valve can prevent the medium in the pipeline from contacting other pipe parts outside the gasket, and avoid the generation of standing water.

The cleanliness of the inner wall of the disc ball valve is relatively high. Among them, the all-inclusive and no dead angle three-piece ball valve is more popular in the pharmaceutical industry. However, the disadvantage of the disc ball valve is that the cost is relatively high.

Non-stagnant ball valve is also called dead angle-free ball valve. Its inner wall is smooth, and its cleanliness is relatively high. It is easy to avoid the breeding of bacteria. This advantage makes it an indispensable valve in the pharmaceutical industry.

It can be expected that with the rapid development of the pharmaceutical industry, the market size of these pharmaceutical valves is expected to grow, and competition among enterprises will be more intense. With the acceleration of the restructuring of the pharmaceutical valve industry, product quality and safety and product brands will become the main factors in the competition of pharmaceutical valves. The products will develop in the direction of high technology, high parameters, strong corrosion resistance, and long life. The level and grade of valve products will also increase. It is expected to improve further.

Generally speaking, the domestic valve industry is an industry with both opportunities and challenges. Although there are many bottlenecks mentioned above, from a broad background, the valve manufacturing industry is gradually shifting from developed countries to developing countries. China has high cost-effectiveness and resource advantages. As downstream pharmaceutical and other industries continue to expand demand for valves, the technology and quality levels of domestic valve companies are gradually increasing, and the cost of valve products is gradually decreasing. The future prospects of domestic valve markets are very optimistic, and domestically strong valves enterprises are expected to win more business opportunities.